Seeking Alpha

More on Cepheid (CPHD) Q4 bottom line beats estimates as results were boosted by stronger sales...

More on Cepheid (CPHD) Q4 bottom line beats estimates as results were boosted by stronger sales and a $5.4M year-earlier charge related to the termination of a patent license. The company issues a downbeat outlook going forward however, projecting weaker-than-expected revenue for 2013. It now sees earnings of between $0.41 to $0.46 per shares on revenue of $375M to $385M. Street expectations were for $0.12 cents and $397M, respectively.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)